International Conference on Nephrology and End-stage Renal Disease (ICNESRD - 26)

This track will explore the latest innovations in dialysis methods, including hemodialysis and peritoneal dialysis. Emphasis will be placed on improving patient outcomes and quality of life through technological advancements.

This session will address the current challenges in kidney transplantation, including organ availability and rejection management. Discussions will focus on novel immunosuppressive therapies and strategies to enhance transplant success.

This track will cover comprehensive management strategies for patients with end-stage renal disease. Topics will include multidisciplinary approaches to care, patient education, and psychosocial support.

This session will highlight cutting-edge research and developments in renal replacement therapies. Participants will discuss the implications of these innovations for clinical practice and patient care.

This track will focus on the specific challenges faced in pediatric nephrology, including congenital anomalies and chronic kidney disease in children. The session aims to foster discussions on tailored treatment approaches and long-term management.

This session will emphasize the importance of early detection and intervention in chronic kidney disease. Participants will explore screening methods, risk factors, and effective management strategies to slow disease progression.

This track will examine the principles of patient-centered care within nephrology. Discussions will focus on shared decision-making, patient engagement, and the role of healthcare providers in enhancing patient experiences.

This session will delve into the critical role of nutrition and metabolism in the management of kidney disease. Topics will include dietary interventions, nutrient management, and their impact on patient outcomes.

This track will explore the ethical dilemmas faced in nephrology, particularly regarding organ allocation and end-of-life decisions. Participants will engage in discussions on ethical frameworks and their application in clinical practice.

This session will focus on the identification and validation of emerging biomarkers for kidney disease. The implications of these biomarkers for diagnosis, prognosis, and treatment will be critically evaluated.

This track will investigate the role of telemedicine in enhancing nephrology care delivery. Discussions will include the benefits, challenges, and future directions of telehealth in managing kidney disease.